Home LiteratureArticle Details
PMID: 6436964 Published · ppublish English Journal Article

Virulence markers in patient and carrier strains of Neisseria meningitidis.

Scandinavian journal of infectious diseases ·Vol. 16 ·No. 3 ·1984-00-00 ·Pages 267-70

Holten E, Frøholm LO, Gaustad P

Abstract

Patient and carrier strains of Neisseria meningitidis from 2 different periods were compared with respect to serogroups, serotypes and sensitivity to sulphadiazine. The majority of 249 patient strains were resistant to sulphadiazine, and belonged to the groups A, B or C. The group B and C strains were mainly type 15/16 and 2, respectively. In contrast, most of the 400 carrier strains belonged to serotypes other than 2 or 15/16, or were non-typable, and most strains were sensitive to sulphadiazine. Among the resistant group B and C carrier strains there were more type 2 and 15/16 strains than would have been expected from the average. The virulence markers: serogroup A, B and C, serotype 2 and 15/16, and resistance to sulphadiazine, coexist in more carrier strains than would be expected if the distribution of these markers was random.

MeSH Terms
Carrier State/drug therapy,microbiology Drug Resistance, Microbial Humans Meningitis, Meningococcal/drug therapy,microbiology Neisseria meningitidis/drug effects,pathogenicity Norway Serotyping Sulfadiazine/therapeutic use Virulence
Chemicals
Sulfadiazine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Holten E
Frøholm L O
Gaustad P
Article Info
Journal
Scandinavian journal of infectious diseases
Abbr.
Scand J Infect Dis
ISSN
0036-5548
Published
1984-00-00
Pages
267-70
Language
English
Region
England
NLM ID
0215333
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com